[
  {
    "ts": null,
    "headline": "Abbott (ABT) Stock Sinks As Market Gains: What You Should Know",
    "summary": "Abbott (ABT) concluded the recent trading session at $129.36, signifying a -1.96% move from its prior day's close.",
    "url": "https://finnhub.io/api/news?id=ad6d29c32f796a724a5436a3d239e2e4556c40aef0e1de6520b4d2c794e1682f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757544602,
      "headline": "Abbott (ABT) Stock Sinks As Market Gains: What You Should Know",
      "id": 136688897,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott (ABT) concluded the recent trading session at $129.36, signifying a -1.96% move from its prior day's close.",
      "url": "https://finnhub.io/api/news?id=ad6d29c32f796a724a5436a3d239e2e4556c40aef0e1de6520b4d2c794e1682f"
    }
  },
  {
    "ts": null,
    "headline": "NVST vs. ABT: Which Stock Should Value Investors Buy Now?",
    "summary": "NVST vs. ABT: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=ffdcd19b837d2bdacab2ac34a9f009e28724eb059862bd57e8e77267bef8eee9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757522403,
      "headline": "NVST vs. ABT: Which Stock Should Value Investors Buy Now?",
      "id": 136688898,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "NVST vs. ABT: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=ffdcd19b837d2bdacab2ac34a9f009e28724eb059862bd57e8e77267bef8eee9"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories stock underperforms Wednesday when compared to competitors",
    "summary": "Abbott Laboratories stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=3460bc8c9c85f52aac8a25fda415e4021dfa360b5444bd01a7d4ded33b8bfb9b",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757521980,
      "headline": "Abbott Laboratories stock underperforms Wednesday when compared to competitors",
      "id": 136713731,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Abbott Laboratories stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=3460bc8c9c85f52aac8a25fda415e4021dfa360b5444bd01a7d4ded33b8bfb9b"
    }
  },
  {
    "ts": null,
    "headline": "MedtechWOMEN Announces Virginia L. Giddings as Winner of the 2025 Ferolyn Powell Award",
    "summary": "MENLO PARK, Calif., September 10, 2025--MedtechWOMEN today announced that Virginia Giddings, Ph.D., vice president of Exploration at Edwards Lifesciences, has been named the recipient of the 2025 Ferolyn Powell Leadership Award, honoring her extraordinary contributions to advancing healthcare innovation, mentoring the next generation of leaders, and fostering diversity in the medical technology industry.",
    "url": "https://finnhub.io/api/news?id=e66a99716dd6e0b26bfcca02052898a50ba03da88e20c9455193508b8dbe7be0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757509200,
      "headline": "MedtechWOMEN Announces Virginia L. Giddings as Winner of the 2025 Ferolyn Powell Award",
      "id": 136688663,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "MENLO PARK, Calif., September 10, 2025--MedtechWOMEN today announced that Virginia Giddings, Ph.D., vice president of Exploration at Edwards Lifesciences, has been named the recipient of the 2025 Ferolyn Powell Leadership Award, honoring her extraordinary contributions to advancing healthcare innovation, mentoring the next generation of leaders, and fostering diversity in the medical technology industry.",
      "url": "https://finnhub.io/api/news?id=e66a99716dd6e0b26bfcca02052898a50ba03da88e20c9455193508b8dbe7be0"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic plc (MDT) Announces FDA Approval for SmartGuard Algorithm as Automated Glycemic Controller",
    "summary": "Medtronic plc (NYSE:MDT) is one of the 14 Tech Stocks to Sell Now According to Ken Fisher. On September 2, 2025, Medtronic plc (NYSE:MDT) announced that the FDA cleared its SmartGuard algorithm as an interoperable automated glycemic controller, allowing its integration with Abbott’s Instinct sensor for type 1 diabetes. At the same time, the company’s […]",
    "url": "https://finnhub.io/api/news?id=f68fa501e14a3e502deb81284584ce6a3c148f86c25ee9f9ca93066d1763ebf3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757498039,
      "headline": "Medtronic plc (MDT) Announces FDA Approval for SmartGuard Algorithm as Automated Glycemic Controller",
      "id": 136688900,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Medtronic plc (NYSE:MDT) is one of the 14 Tech Stocks to Sell Now According to Ken Fisher. On September 2, 2025, Medtronic plc (NYSE:MDT) announced that the FDA cleared its SmartGuard algorithm as an interoperable automated glycemic controller, allowing its integration with Abbott’s Instinct sensor for type 1 diabetes. At the same time, the company’s […]",
      "url": "https://finnhub.io/api/news?id=f68fa501e14a3e502deb81284584ce6a3c148f86c25ee9f9ca93066d1763ebf3"
    }
  }
]